HLS Therapeutics Inc
OTC:HLTRF
HLS Therapeutics Inc
OTC:HLTRF
Price:
3
USD
Market Closed
Market Cap:
$95.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
HLS Therapeutics Inc
OTC:HLTRF
|
CA |
|
First Western Financial Inc
NASDAQ:MYFW
|
US |
|
WuXi AppTec Co Ltd
SSE:603259
|
CN |
|
Y
|
Yatsen Holding Ltd
NYSE:YSG
|
CN |
|
A
|
Airea PLC
LSE:AIEA
|
UK |
|
Jiangsu Hengli Hydraulic Co Ltd
SSE:601100
|
CN |
|
Lingbao Gold Group Company Ltd
HKEX:3330
|
CN |
|
S
|
Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF
|
SE |
|
T
|
Taekyung Chemical Co Ltd
KRX:006890
|
KR |
|
W
|
Winfarm SA
PAR:ALWF
|
FR |
|
biOasis Technologies Inc
XTSX:BTI
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
HLTRF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3 USD,
HLS Therapeutics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HLTRF Multiples-Based Value
LOCKED
Multiples Across Competitors
HLTRF Competitors Multiples
HLS Therapeutics Inc Competitors
HLS Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
HLS Therapeutics Inc
OTC:HLTRF
|
137m USD | 1.8 | -8 | 8.2 | -24.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.8B USD | 0.3 | 24.4 | 17.1 | 19.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.1B USD | 0.2 | 38.2 | 13.5 | 17.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.8B USD | 0.2 | 37.4 | 13.3 | 16.8 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.8B USD | 0.2 | 29.3 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.1B AUD | 2.6 | 33.1 | 24.6 | 24.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61B CNY | 0.2 | 10.8 | 14.8 | 14.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.3B USD | 0.6 | 21 | 10.3 | 14.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.4 | 15.9 | 12.2 | 12.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63B HKD | 0.1 | 7.9 | 0.6 | 0.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
